- Article metrics
- Last updated: Fri, 17 May 2024 12:06:54 Z
Cost-utility analysis of palivizumab for preventing respiratory syncytial virus in preterm neonates and infants in Colombia
Access & Citations
-
- 378
- Article Accesses
-
- 0
- Web of Science
-
- 0
- CrossRef
Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.